In this sense, we also acknowledge that potential dysregulation of inflammation-related genes included in our proposed molecular signature (e.g., IL1A, MCM2, MMP1, MMP12, and VEGFA) might be due to the inflammation favoring tumor maintenance and progression [50,51]. The gene discussed is MMP1; the disease is neoplasm.